Advertisement

Chinese Journal of Integrative Medicine

, Volume 25, Issue 1, pp 71–79 | Cite as

Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)

  • Liang Dai
  • Chung-wah Cheng
  • Ran Tian
  • Linda LD Zhong
  • You-ping Li
  • Ai-ping Lyu
  • An-wen Chan
  • Hong-cai Shang
  • Zhao-xiang BianEmail author
Regulation and Guideline

Abstract

Traditional Chinese Medicine (TCM) is one of the oldest systems of medicine. More and more attention has been paid to TCM application, but the variable quality of clinical trials with TCM impedes its widespread acceptance. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Statement has established guidelines for designing clinical trials to ensure that the trial results are accurate and reliable. However, there are difficulties when applying SPIRIT 2013 Statement to trials with TCM, due to the unique theory and the characteristic of TCM intervention. An Extension to the original SPIRIT was developed to ensure the quality of trial design with TCM. As Chinese herbal formulae, acupuncture and moxibustion are common and representative interventions in TCM practice, the executive working group determined that the SPIRIT-TCM Extension focus on these three interventions. Extension was developed through initiation, 3 rounds of Delphi consensus survey, and finalizing expert meeting. Seven items from the SPIRIT 2013 Statement were modified, namely, "title", "background and rationale", "objectives", "eligibility criteria", "interventions", "outcomes", and "data collection methods". The Extension includes the introduction of the concept of TCM pattern and 3 major TCM interventions, with examples and explanations. The SPIRIT-TCM Extension 2018 provides suggestion for investigators in designing high quality TCM clinical trials. It is expected that wide dissemination and application of this extension ensure continuous improvement of TCM trial quality throughout the world.

Keywords

SPIRIT traditional Chinese medicine clinical trial extension recommendation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgement

We thanks David Moher for his critical comments about this project. Special thanks for Dr. Martha Dahlen for her help in polishing this manuscript.

Supplementary material

11655_2018_2999_MOESM1_ESM.pdf (983 kb)
Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)

References

  1. 1.
    World Health Organization. WHO traditional medicine strategy 2014–2023. Accessed Dec 2013. Cited 20 Dec 2017. Available from: https://doi.org/apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf?ua=1.
  2. 2.
    Chen KJ, Qian ZH, Zhang WQ, Guan WR, Wu XG, Chen XJ, et al. Effectiveness analysis for double blinded treatment with refined coronary tablets on angina pectoris leaded by coronary heart disease in 112 cases. J Med Res (Chin) 1982;11:24–25.Google Scholar
  3. 3.
    Wieland LS, Manheimer E, Sampson M, Barnabas JP, Bouter LM, Cho K, et al. Bibliometric and content analysis of the Cochrane complementary medicine field specialized register of controlled trials. Syst Rev 2013;2:51.CrossRefGoogle Scholar
  4. 4.
    Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 2012;1:60.CrossRefGoogle Scholar
  5. 5.
    MacPherson H, Altman DG, Hammerschlag R, Li Y, Wu T, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Acupunct Med 2010;28:83–93.CrossRefGoogle Scholar
  6. 6.
    Cheng CW, Fu SF, Zhou QH, Wu TX, Shang HC, Tang XD, et al. Extending the CONSORT Statement to moxibustion. J Integr Med 2013;11:54–63.CrossRefGoogle Scholar
  7. 7.
    Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, et al. CONSORT extension for Chinese herbal medicine formulae 2017: recommendations, explanation and elaboration. Ann Intern Med 2017 Jun 27. doi: 10.7326/M16-2977.Google Scholar
  8. 8.
    Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586.CrossRefGoogle Scholar
  9. 9.
    The SPIRIT Statement. Endorsement. Accessed 20 Dec 2017. Available at: https://doi.org/www.spirit-statement.org/aboutspirit/spirit-endorsement.
  10. 10.
    Zhong LD, Cheng CW, Wu TX, Li YP, Shang HC, Zhang BL, et al. SPIRIT 2013 statement: define standard protocol items for clinical trials. Chin J Integr Tradit West Med (Chin) 2014;34:115–122.Google Scholar
  11. 11.
    Han M, Yang GY, Wang YY, Liu JP. Chinese medicine clinical trial protocol design and report specifications. Chin J Integr Tradit West Med (Chin) 2014;34:907–910.Google Scholar
  12. 12.
    Shen WJ, Wu XK, Wang GY, Liu JP. Common problems and solving strategy of clinical trial protocols of traditional Chinese medicine. Acta Chin Med Pharmacol (Chin) 2015;43:1–4.Google Scholar
  13. 13.
    Integrative Traditional and Western Medicine Branch of Chinese Medical Doctor Association, Evidence-based Medicine Professional Committee of Chinese Integrative Medicine Association. Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine}. Chin J Integr Tradit West Med (Chin)} 2015};35}:901–Google Scholar
  14. 14.
    Liu YX. Randomization of clinical trials. J Med Postgrad (Chin) 2015;28:113–117.Google Scholar
  15. 15.
    Tan Y, Zhao Y, He T, Ma Y, Cai W, Wang Y. Efficacy and safety of auricular point acupressure treatment of gastrointestinal dysfunction after laparoscopic cholecystectomy: study protocol for a randomized controlled trials. Trials 2016;17:280.CrossRefGoogle Scholar
  16. 16.
    Wang S, Jiang H, Yu Q, She B, Mao B. Efficacy and safety of Lian-Ju-Gan-Mao Capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial. Trials 2017;18:2.CrossRefGoogle Scholar
  17. 17.
    Bian ZX, Chang YH. Revised STRICTA as an extension of the CONSORT statement: more items should be involved in the checklist. J Altern Complement Med 2011;17:97–98.CrossRefGoogle Scholar
  18. 18.
    Scheid V. Convergent lines of descent: symptoms, patterns, constellations, and the emergent interface of systems biology and Chinese medicine. East Asian Sci Technol Soc 2014;8:107–139.CrossRefGoogle Scholar
  19. 19.
    World Health Organization. WHO international standard terminologies on traditional medicine in the western pacific region. 2007. Accessed 20 Dec 2017. Available at: https://doi.org/www.wpro.who.int/publications/who_istrm_file.pdf.
  20. 20.
    Lu A, Jiang M, Zhang C, Chan K. An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis. J Ethnopharmacol 2012;141:549–556.CrossRefGoogle Scholar
  21. 21.
    Tang Q. Syndrome diagnosis criteria and therapeutic schedule for depression. J Beijing Univ Tradit Chin Med (Chin) 2011;34:810–811.Google Scholar
  22. 22.
    Li J, Wang Z, Li S, Li Y, Zhang HC, Chao E, et al. Syndrome diagnosis criteria for common cold (2013 version). J Tradit Chin Med (Chin) 2014;55:350–351.Google Scholar
  23. 23.
    Bian ZX, Moher D, Dagenais S, Li YP, Liu L, Wu TX, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part ?: control group design. J Chin Integr Med (Chin) 2006;4:130–136.CrossRefGoogle Scholar
  24. 24.
    Zhang YC, Li G, Jiang C, Yang B, Yang HJ, Xu HY, et al. Tissue-specific distribution of ginsenosides in different aged ginseng and antioxidant activity of ginseng leaf. Molecules 2014;19:17381–17399.CrossRefGoogle Scholar
  25. 25.
    Li YH, Chen F, Wang JF, Wang Y, Zhang JQ, Guo T. Analysis of nine compounds from Alpinia oxyphylla fruit at different harvest time using UFLC-MS/MS and an extraction method optimized by orthogonal design. Chem Cent J 2013;7:134.CrossRefGoogle Scholar
  26. 26.
    Su T, Yu H, Kwan HY, Ma XQ, Cao HH, Cheng CY, et al. Comparisons of the chemical profiles, cytotoxicities and antiinflammatory effects of raw and rice wine-processed Herba Siegesbeckiae. J Ethnopharmacol 2014;156:365–369.CrossRefGoogle Scholar
  27. 27.
    Zhang ZZ, Tian D, Xing J, Li ZY, Qin XM. Quality comparison on Farfarae Flos from various origins by UPLC based on multi-components content determination method. Chin Tradit Herb Drugs (Chin) 2015;46:2296–2302.Google Scholar
  28. 28.
    Zhang S, Mu W, Xiao L, Zheng WK, Liu CX, Zhang L, et al. Is deqi an indicator of clinical efficacy of acupuncture? A systematic review. Evid Based Complement Alternat Med 2013;2013:750140.Google Scholar
  29. 29.
    Luo J, Xu H, Liu B. Real world research: a complementary method to establish the effectiveness of acupuncture. BMC Complement Altern Med 2015;15:153.CrossRefGoogle Scholar
  30. 30.
    Deng H, Shen X. The mechanism of moxibustion: ancient theory and modern research. Evid Based Complement Alternat Med 2013;2013:379291.CrossRefGoogle Scholar
  31. 31.
    Streitberger K, Kleinhenz J. Introducing a placebo needle into acupuncture research. Lancet 1998;352:364–365.CrossRefGoogle Scholar
  32. 32.
    Zhao B, Wang X, Lin Z, Liu R, Lao L. A novel sham moxibustion device: a randomized, placebo-controlled trial. Complement Ther Med 2006;14:53–60.CrossRefGoogle Scholar
  33. 33.
    Bian ZX, Moher D, Li YP, Wu TX, Dagenais S, Cheng CW, et al. Appropriately selecting and concisely reporting the outcome measures of randomized controlled trials of traditional Chinese medicine. J Chin Integr Med (Chin) 2008;6:771–775.CrossRefGoogle Scholar
  34. 34.
    Zhang L, Zhang J, Chen J, Xing D, Mu W, Wang J, et al. Clinical research of traditional Chinese medicine needs to develop its own system of core outcome sets. Evid Based Complement Alternat Med 2013;2013:202703.Google Scholar
  35. 35.
    Administration CFDA. Announcement of self-examination and inspection of drug clinical trial data. 2015. Accessed 20 Dec 2017. Available at: https://doi.org/www.sda.gov.cn/WS01/CL0087/124800.html.

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine 2018

Authors and Affiliations

  • Liang Dai
    • 1
    • 2
  • Chung-wah Cheng
    • 1
  • Ran Tian
    • 1
  • Linda LD Zhong
    • 1
  • You-ping Li
    • 3
  • Ai-ping Lyu
    • 1
  • An-wen Chan
    • 4
  • Hong-cai Shang
    • 5
  • Zhao-xiang Bian
    • 1
    Email author
  1. 1.Hong Kong Chinese Medicine Clinical Study Centre, School of Chinese MedicineHong Kong Baptist UniversityHong Kong SARChina
  2. 2.Institute of Digestive Diseases, Longhua HospitalShanghai University of Traditional Chinese MedicineShanghaiChina
  3. 3.Chinese Evidence-Based Medicine CentreSichuan UniversityChengduChina
  4. 4.Women’s College Research Institute, Women’s College HospitalUniversity of TorontoTorontoCanada
  5. 5.Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen HospitalBeijing University of Chinese MedicineBeijingChina

Personalised recommendations